Solara Active Pharma Sciences informs about earnings call transcript

31 Jan 2025 Evaluate
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Solara Active Pharma Sciences has enclosed the transcript of the earnings conference call for the quarter ended December 31, 2024, conducted after the meeting of Board of Directors held on January 24, 2025, for information and records. The above information is also available on the website of Company at: https://solara.co.in/investorrelations/investor-update

The above information is a part of company’s filings submitted to BSE.

Solara Active Pharma Share Price

471.75 1.05 (0.22%)
28-Feb-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1593.90
Dr. Reddys Lab 1117.65
Cipla 1410.95
Lupin 1906.20
Zydus Lifesciences 876.20
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...